Stephan Ladisch, M.D., professor of pediatrics and professor of biochemistry and molecular biology, was featured in Medical Xpress for recently published research in the American Society of Hematology journal, Blood. The international study found that prolonged, intense initial treatment in children with multi-system Langerhans cell histiocytosis (MS-LCH) can achieve survival rates as high as 84 percent—a full 15 percent improvement over his previous clinical trial. This research was also featured in Science Codex.
Medical Xpress - Study Shows Longer Treatment for Children With Langerhans Cell Hystiocytosis Improves Survival Rates
Latest News
The Global Clinical Care Alliance (GCCA) at the George Washington University (GW) School of Medicine and Health Sciences (SMHS) announced the inaugural recipients of the GW Global Health Legacy Fellowship.
As fall begins and school resumes, the GW Cancer Center extends vital support to patients who are also parents. Led by Access Team Lead Janelle Williams, the center offers compassionate programs like school supply drives to ease the burden on families affected by cancer.
The International Association for Health Professions Education (AMEE) recently selected Maranda Ward, EdD ’17, MPH, associate professor of clinical research and leadership, as the recipient of the 2025 Miriam Friedman Ben-David (MFBD) Award.